Pablo Umaña

18PUBLICATIONS

194CO-AUTHORS

Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 12, 2026

Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

|Apr 21, 2026

FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumours.

|Sep 17, 2025

PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer.

Irene Fusi, Clara Serger, Petra Herzig

|Apr 16, 2024

The physiological interactome of TCR-like antibody therapeutics in human tissues.

Estelle Marrer-Berger, Annalisa Nicastri, Angelique Augustin

|Mar 04, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

|Feb 06, 2024

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.

Solange Peters, Eric Angevin, Teresa Alonso-Gordoa

Pageof 3

Frequent Collaborators

16 joint publications

Christian Klein

Laura Codarri Deak

Johannes Sam

Stefanie Briner

Valeria Nicolini

Masao Hashimoto

Marina Bacac

Sara Colombetti

Anne Freimoser-Grundschober

3 joint publications

Haydn T Kissick

Frequent Collaborators

16 joint publications

Christian Klein

4 joint publications

Laura Codarri Deak

4 joint publications

Johannes Sam

4 joint publications

Stefanie Briner